BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 10, 2017
View Archived Issues
Preclinical characterization of a novel selective PI3Kalpha inhibitor, GDC-0077
Read More
LY-3214996 demonstrates potent antitumor activity in cancer models with MAPK pathway alterations
Read More
Discovery and preclinical characterization of novel JAK1 inhibitor AZD-4205
Read More
FDA approves Gilead Sciences' Harvoni and Sovaldi in pediatric patients
Read More
First data from first-in-human study of FGFR-4 inhibitor FGF-401 reported
Read More
Janssen identifies novel FGFR inhibitors
Read More
NSTDA patents dihydrofolate reductase inhibitors
Read More
Merck KGaA discloses new IRAK-1/4 inhibitors
Read More
IASOtoc now available in France, Austria and Germany
Read More
Phase II PREVACEbola vaccine study launched in West Africa to evaluate three vaccination strategies
Read More
Akorn and Fresenius Kabi in discussions regarding potential acquisition
Read More
PeptiDream and Janssen enter discovery and collaboration agreement
Read More
Kyowa Hakko Kirin announces positive results from the phase III MAVORIC clinical trial
Read More
Themis Bioscience initiates phase I dose-finding study of MV-ZIKA vaccine
Read More
Kura Oncology begins phase I study of KO-947 in nonhematological malignancies
Read More
Sunshine Lake Pharma, Calitor Sciences patent JAK, FLT-3 and Aurora kinase inhibitors
Read More
Medivir announces completion of phase II remetinostat study in CTCL
Read More
Assembly Biosciences, IURTC present HBV core protein modulators
Read More
Fred Hutch announces faculty and staff achievements
Read More
FDA issues complete response letter regarding Merck & Co.'s sitagliption sNDAs
Read More
Celgene describes in vivo antitumor activity of anti-CD47 monoclonal antibody CC-90002
Read More
Cipla and MEDRx enter into a collaboration for MRX-4TZT
Read More
Nanotherapeutics begins enrollment in phase I trial of NTM-1634
Read More
Indian FDA approves first autologous dendritic cell-based immuno-oncology product
Read More